Curemark, LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile by GlobalData

VIEWS: 3 PAGES: 15

More Info
									        Curemark, LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
       Reference Code: GDPH133707D                                                                                                               Publication Date: JAN 2013

      Company Overview                                                                                        Key Facts
      Curemark, LLC (Curemark) is a biotechnology company, based in the US. The
                                                                                                              Curemark, LLC, Pharmaceuticals & Healthcare, Key
      company develops and markets drugs for the treatment of neurological diseases. It
                                                                                                              Facts
      provides biomarker and pancreatic enzyme products for diagnosing and treating
      children with autism spectrum disorders. Curemark develops drugs for the treatment                       Web Address                              www.curemark.com
      of autism, dysautonomias, attention deficit disorder and Parkinson’s disease. The
                                                                                                               Revenue (US$ million)                                   NA
      company also develops drugs for gastrointestinal and pancreatic secretory
      deficiencies in neurological conditions for children and adults. Its breakthrough                        Number of Employees                                     NA
      products are based on proprietary technology. Curemark is headquartered in Rye,                          GlobalData
      New York, the US.

      Financial Deals Landscape
        Curemark, LLC, Pharmaceuticals & Healthcare, Deals by Type,                       Curemark, LLC, Pharmaceuticals & Healthcare, Deals By
        2007 to YTD 2013                                                                  Year, 2007 to YTD 2013


                                                                                                                                   1         1               1
                                                                                                          1




                                                                                           No. of Deals

                                                                                                                 0         0                            0               0
                                                                                                          0
                                                                                                               2007       2008    2009     2010     2011    2012       YTD
                                                                                                                                                                       2013


                                                                                          Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from
                                                                                          from 2006 onwards, GlobalData
         2006 onwards, GlobalData


         Curemark, LLC, Pharmaceuticals & Healthcare, Deals By                            Curemark, LLC, Pharmaceuticals & Healthcare, Deals By
         Region, 2007 to YTD 2013                                                         Therapy Area, 2007 to YTD 2013


                         3                                                                                            3                3
          No. of Deals




                                                                                                          3
                               3
                                                                                           No. of Deals




                         2
                                                                                                          2
                         1
                                        0         0        0         0                                    1
                         0
                             North    Asia-     Europe   Middle   South                                                                             0              0
                             Americ   Pacific             East     and                                    0
                               a                          and     Central                                        Central         Gastroint       Cardiova Metabolic
                                                         Africa   Americ                                         Nervous          estinal         scular  Disorder
                                                                    a                                            System                                      s



         Note: Deals include all announced pharmaceuticals & healthcare deals             Note: Deals include all announced pharmaceuticals & healthcare deals
         from 2006 onwards, GlobalData                                                    from 2006 onwards, GlobalData




Curemark, LLC - Pharmaceuticals & Healthcare - Deals and                                                                                           Reference Code: GDPH133707D
Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                    Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Curemark, LLC, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ......................................................................... 3
       Curemark, LLC, Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 .......................................................................... 5
       Curemark, LLC, Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 ..................................................................... 6
       Curemark, LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 ........................................................... 7
       Curemark, LLC, Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013....................................................................... 8
       Curemark, LLC, Pharmaceuticals & Healthcare, Deal Details ............................................................................................................ 9
          Venture Financing........................................................................................................................................................................... 9
             Curemark Raises $2.3 Million In Venture Financing.................................................................................................................... 9
             Curemark Raises $5.22 Million In Venture Financing................................................................................................................ 10
             Curemark Raises $6.5 Million In Series A Financing Round ..................................................................................................... 11
       Curemark, LLC - Key Competitors ................................................................................................................................................... 12
       Key Employees .......................................................
								
To top